Anxiety and depression and their impact on functional recovery and quality of life in Guillain-Barré syndrome: a prospective cohort study in Bangladesh.

At week 13, 45% had anxiety reducing to 36% at week 26.

Baseline bulbar involvement was significantly associated with week 13 depression and week 26 anxiety.

Between week 13 and week 26, 27%-30% of patients had persistent symptoms and 13%-16% experienced worsening.

Anxiety and depression mostly followed concordant patterns, though 28 patients showed discordant patterns.